Fennec Pharmaceuticals Inc (NAS:FENC)
$ 4.505 0.275 (6.5%) Market Cap: 123.92 Mil Enterprise Value: 105.09 Mil PE Ratio: 112.63 PB Ratio: 0 GF Score: 27/100

Fennec Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 14, 2022 / 03:00PM GMT
Release Date Price: $5.59 (+1.54%)
Khalid Islam
Fennec Pharmaceuticals Inc. - Chairman

Good morning, ladies and gentlemen, and welcome to this Annual Meeting of Shareholders of Fennec Pharmaceuticals Inc. I'm Khalid Islam, the Chairman of the Board of the company, and I'll be chairing this meeting, which I now call to order. We'll begin with the formal legal business of the meeting. After the formal business has been concluded, Mr. Rosty Raykov, our CEO will provide a presentation on the company's business progress. Following the presentation, we will hold a question and answer session where you'll have an opportunity to ask questions.

As Chairman, I appoint Randy Taylor to act as secretary and scrutineer for this meeting. [Mongolin] will act as in-person scrutineer combination. The notice calling this meeting, together with the related management information circular dated April 20, 2022, and a form of proxy was mailed to shareholders as required by statute.

I received a statutory declaration from [Broadrick] attesting to the mailing, and I direct the secretary to touch a declaration to the minutes of this meeting.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot